gene therapy

Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program
Fierce Biotech
Mon, 02/2/15 - 08:08 am
Bluebird Bio
gene therapy
beta-thalassemia
LentiGlobin BB305
Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia
Fierce Biotech
Thu, 01/29/15 - 09:41 am
Biogen Idec
hemophilia B
hemophilia A
hemophilia
gene therapy
Pfizer (PFE) Enters Gene Therapy Arena; Offers To Settle Class Action Over Parkinson’s Drug
Bidness Etc.
Wed, 12/10/14 - 08:45 am
Pfizer
gene therapy
Spark Therapeutics
SPK-FIX
hemophilia B
Astellas dives into gene therapy with a Harvard expert in tow
Fierce Biotech
Tue, 10/14/14 - 09:23 pm
Astellas
gene therapy
Retinitis pigmentosa
Genzyme to Collaborate on Gene Therapy for Blindness-Causing Diseas
Drug Discovery and Development
Fri, 09/26/14 - 12:06 pm
gene therapy
Genzyme
Sanofi
Biogen shoulders into gene therapy amid a second honeymoon for the field
Fierce Biotech
Wed, 09/24/14 - 08:42 am
Biogen Idec
gene therapy
R&D pioneer tackles the next hurdle in gene therapy: Paying for $1M-plus drugs
Fierce Biotech
Thu, 09/11/14 - 08:19 am
R&D
gene therapy
drug pricing
Gene therapy biotech Avalanche banks $102M in an up-sized IPO
Fierce Biotech
Thu, 07/31/14 - 10:04 am
gene therapy
Avalanche Biotechnologies
IPOs
Is Gene Therapy Medicine's Next Big Thing?
Motley Fool
Sun, 06/15/14 - 07:04 pm
gene therapy
Bluebird Bio
Gene Therapy's Big Comeback
Forbes
Wed, 03/26/14 - 08:07 am
gene therapy
Bristol-Myers Squibb
Bluebird Bio
NightstaRx
Voyager Therapeutics
uniQure
Celladon
Juno Therapeutics
Editas Medicine
Gensight Biologics
Audentes Therapeutics
Dimension Therapeutics
Bluebird Bio May Turn Dreams Into Reality
Seeking Alpha
Fri, 02/28/14 - 10:33 am
Bluebird Bio
gene therapy
Third Rock puts up $45M for a voyage into gene therapy
Fierce Biotech
Thu, 02/13/14 - 11:14 am
Third Rock
gene therapy
Voyager Therapeutics
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
TheStreet.com
Thu, 01/23/14 - 09:53 am
gene therapy
Biogen Idec
Sangamo BioSciences
Bluebird Bio
Acceleron
Oxford gene trial makes eye disease breakthrough
FT.com
Thu, 01/16/14 - 06:52 am
Oxford BioMedica
choroideremia
gene therapy
blindness
Boehringer Ingelheim fuels gene therapy startup focused on eye diseases
Fierce Biotech
Fri, 04/12/13 - 01:49 pm
Boehringer Ingelheim
gene therapy
Eyevensys
Boehringer Ingelheim Venture Fund
Gene Therapy Takes a Turn for the Better
Businessweek
Fri, 04/23/10 - 11:25 am
gene therapy
Genzyme
Roche/Genentech
Genetix
Novartis $214M Deal with GenVec Tests Gene Therapy Waters
BNET Pharma
Thu, 01/21/10 - 09:04 am
GenVec
gene therapy
Novartis
partnerships

Pages